Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
DBGen Ocular Genomics | RCV001526707 | SCV001737129 | likely pathogenic | Severe early-childhood-onset retinal dystrophy | 2021-05-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002568845 | SCV003343829 | uncertain significance | not provided | 2022-09-05 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ABCA4 protein function. ClinVar contains an entry for this variant (Variation ID: 1172702). This variant has not been reported in the literature in individuals affected with ABCA4-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces proline, which is neutral and non-polar, with histidine, which is basic and polar, at codon 2103 of the ABCA4 protein (p.Pro2103His). |
Ophthalmo- |
RCV002469401 | SCV002765144 | pathogenic | Stargardt disease | 2022-12-20 | no assertion criteria provided | research | PM1,PP2,PM2,PP3,PP5 ACMG Criteria |